Eye Doctor and Fox News Regular Eyed as New Head of FDA Vaccine Division
FDA may pick Dr. Hemmati to lead CBER, which could speed up vaccine and biotech drug approvals, but decision is not final.
/ 12 items
#XY News-Driven Stocks↓
Jhunjhunwala-Backed IKS in Advanced Talks to Buy Nasdaq’s TruBridge for $600M
IKS nearing $600M buy of TruBridge to boost US healthcare billing/RCM, expand AI-driven services and market share.
Sun Pharma Makes Massive $12 Billion Binding Offer for US Firm Organon
Sun Pharma fell 4% after a $12B bid for Organon, raising debt worries despite strong cash and ongoing deal talks.
Gilead’s $5B Tubulis Deal Validates ADC Space – Bullish for Sutro Biopharma
Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.
Perrigo Stock Jumps on Takeover Rumors from German Drugmaker Stada
Perrigo Co. stock rose on takeover rumors, possibly by Stada Arzneimittel AG. No deal confirmed yet.
Amgen’s Easy “On-Body” Tepezza Shot Crushes Phase 3 — Viridian Stock Plunges
Viridian shares fell after Amgen’s new, easy Tepezza shot showed strong results for Thyroid Eye Disease.